Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 33 min ago
PreprintCC BY-NC-NDbioRxiv

Phenotypes of ultra-rare variant carriers benchmark variant effect scores

  1. 1School of Computation, Information and Technology, Technical University of Munich, Garching, Germany

Abstract

Human genetics needs benchmarks for evaluating variant scores against observed phenotypic consequences. We therefore present UKBBGym, which evaluates coding and non-coding scores against plasma protein abundance and quantitative traits observed in carriers of ultra-rare variants in the UK Biobank. This design avoids ascertainment biases of clinical labels, potential physiological mismatch of experimental assays, and confounding pertaining to common-variant associations. UKBBGym recapitulates relative performance on pathogenicity prediction while enabling comparison across variant classes and molecular mechanisms. This shows that scores designed for coding and splicing variants correlate more strongly with protein abundance and quantitative traits than scores modelling transcriptional regulation. Moreover, experimental assays do not consistently outperform computational scores for predicting missense effects. Comparing captured to detectable variance indicates scope for improvement, particularly for indels and loss-of-function variants. Finally, for coding variants, UKBBGym can be reproduced from public summary statistics, providing an accessible population-phenotype benchmark complementary to clinical labels and experimental assays.

Related

  1. Trends in the uptake of nipple sparing mastectomy in BRCA1/2, PALB2 and other pathogenic variant carriers undergoing risk reducing mastectomy.
    Marya Alsuhaibani, Amel Melanson, Alex Viezel-Mathieu +10
    Hereditary cancer in clinical practicePeer-reviewedCC BYFull textGenetics & genomicsEurope PMCDOAJ
  2. GeneSIS: enhancing transferability of polygenic scores with variant-level gene-by-sex interaction effects
    Y. Tanigawa, M. Kellis
    bioRxivPreprintCC BYFull textGenetics & genomicsbioRxiv
  3. Cis-Attenuation of Pathogenic Scn8a Variant Causing Childhood Epilepsy Reveals Opposing Transcriptional Programs Driving NaV1.6 Gain and Loss of Function Phenotypes
    M. F. Hammer, E. Bahramnejad
    bioRxivPreprintAll rights reservedFull textGenetics & genomicsbioRxiv
  4. A Novel Homozygous Variant Associated With Distinct Clinical Phenotypes of SDR9C7 Nonsyndromic Epidermal Differentiation Disorder in Two Affected Patients From a Consanguineous Saudi Family
    Faisal Almalki, Zaker Khoj, Essa Alharbi +1
    Molecular genetics & genomic medicinePeer-reviewedCC BY-NCFull textGenetics & genomicsEurope PMC
  5. Calibration of AlphaGenome Variant Impact and SpliceAI2 scores as PP3/BP4 evidence for missense, non-coding, and synonymous variants
    A. Babazade, Y. Dolas, T. Duzenli +3
    bioRxivPreprintCC BY-NC-NDFull textGenetics & genomicsbioRxiv
BibTeX
@misc{londhe2026phenotypes,
  title = {{Phenotypes of ultra-rare variant carriers benchmark variant effect scores}},
  author = {S. Londhe and E. Holtkamp and G. Tsitsiridis and A. Starovoit and P. Tomaz da Silva and J. Hingerl and H. Finucane and J. Gagneur},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.01.755962},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.01.755962v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Phenotypes of ultra-rare variant carriers benchmark variant effect scores
AU  - S. Londhe
AU  - E. Holtkamp
AU  - G. Tsitsiridis
AU  - A. Starovoit
AU  - P. Tomaz da Silva
AU  - J. Hingerl
AU  - H. Finucane
AU  - J. Gagneur
PY  - 2026
DA  - 2026/10/01
PB  - bioRxiv
DO  - 10.64898/2026.10.01.755962
UR  - https://www.biorxiv.org/content/10.64898/2026.10.01.755962v1
AB  - Human genetics needs benchmarks for evaluating variant scores against observed phenotypic consequences. We therefore present UKBBGym, which evaluates coding and non-coding scores against plasma protein abundance and quantitative traits observed in carriers of ultra-rare variants in the UK Biobank. This design avoids ascertainment biases of clinical labels, potential physiological mismatch of experimental assays, and confounding pertaining to common-variant associations. UKBBGym recapitulates relative performance on pathogenicity prediction while enabling comparison across variant classes and molecular mechanisms. This shows that scores designed for coding and splicing variants correlate more strongly with protein abundance and quantitative traits than scores modelling transcriptional regulation. Moreover, experimental assays do not consistently outperform computational scores for predicting missense effects. Comparing captured to detectable variance indicates scope for improvement, particularly for indels and loss-of-function variants. Finally, for coding variants, UKBBGym can be reproduced from public summary statistics, providing an accessible population-phenotype benchmark complementary to clinical labels and experimental assays.
ER  -